ACT-HBV® : Advancing the Clinical Treatment of Hepatitis B Virus
Home CME Center Clinical Trials About ACT-HBV® Treatment Algorithms and Guidelines Ask the Experts
ACT-HBV.com will continue to offer innovative online CME activities in the coming months. If you'd like to receive updates about new CME activities, please take a moment to sign up below.
(* indicates required fields)
 
* First Name:
* Last Name:
* E-mail:
  Submit
 
 
Online ResourcesContact Us Refer a Colleague Send Me Updates Legal Disclaimer
  
   
 
MDGUniversity of Wisconsin Medical School
The ACT-HBV Initiative in the United States is supported by independent educational grants from Bristol-Myers Squibb Company and Gilead Sciences. The ACT-HBV Initiative in the Asia-Pacific Region is supported by independent educational grants from Bristol-Myers Squibb Company and Novartis Pharma AG.